15 Apr, 2026
Feel free to reach out to us.
15 Apr, 2026
Most people first hear the words "throat cancer" during a consultation they almost skipped. A hoarse voice that lingered a few weeks too long. A neck lump that did not go away. Throat cancer originates in the pharynx or larynx, the paired structures that handle breathing, speech, and swallowing. Several distinct subtypes exist, each behaving differently depending on where the tumor begins. Tobacco, heavy alcohol use, and certain strains of HPV are the most established triggers. Catching this cancer before it has spread to the lymph nodes changes the treatment picture considerably.
The throat includes two main zones: the pharynx, a muscular passage running from the back of the nose down to the esophagus, and the larynx, which sits lower and holds the vocal cords. Cancer can take root in either zone.
Squamous cell carcinoma is by far the most common form. It starts in the thin, flat cells that line the inner surfaces of these passages. Rarer variants such as adenocarcinoma or lymphoma do occur, though they represent a much smaller portion of cases.
Good to Know: Where the tumor starts determines almost everything, including which symptoms appear first, how it spreads, and how it responds to treatment.
| Type | Location | Main Risk Factor |
|---|---|---|
| Laryngeal cancer | Voice box | Tobacco, alcohol |
| Oropharyngeal cancer | Back of throat, tonsils | HPV, tobacco |
| Hypopharyngeal cancer | Lower pharynx | Heavy tobacco and alcohol |
| Nasopharyngeal cancer | Upper pharynx, nasal area | EBV, genetic factors |
Symptoms shift depending on which part of the throat is affected. Laryngeal tumors tend to show themselves early through the voice. Patients describe a roughness or strain in their speech, like speaking through gravel, that does not clear with rest or fluids. That particular quality is worth paying attention to.
Oropharyngeal tumors are quieter at first. A firm, nontender lump on one side of the neck, caused by an enlarged lymph node, is sometimes the only early sign. Hypopharyngeal cancer can grow silently for months, surfacing only when swallowing becomes noticeably difficult or mildly painful.
Common Confusion: Persistent hoarseness is blamed on reflux or post-viral irritation far more often than it should be. Three weeks is the threshold. Beyond that point, a specialist needs to look.
Tobacco use sits at the top of the list in India. Cigarettes, bidis, and smokeless products, including gutka, pan masala, and khaini, all deliver carcinogens directly to the mucosal lining of the pharynx and larynx. Alcohol significantly amplifies this risk by loosening the mucosal barrier, allowing carcinogens to penetrate more deeply.
HPV-16, a sexually transmitted viral strain, is now responsible for a growing share of oropharyngeal cancers, particularly among younger adults who have never smoked. This subtype tends to respond well to chemoradiation. HPV vaccination during adolescence, before exposure occurs, may reduce long-term risk.
Betel nut, used widely across South Asia in various forms, adds independent mucosal carcinogen exposure. Chronic acid reflux reaching the larynx, prior radiation to the head or neck region, occupational exposure to wood dust or asbestos, and low dietary vitamin A intake round out the contributing risk factors.
In summary: Tobacco and alcohol in combination carry a disproportionately higher risk than either substance alone. Stopping both before treatment begins improves how well the body tolerates therapy.
A head and neck specialist typically begins with a fiberoptic nasolaryngoscopy, passing a slim, flexible camera through the nasal passage to directly inspect the pharynx and larynx. Any suspicious area is then sampled through endoscopic biopsy, and the extracted tissue is examined under a microscope to confirm malignancy and determine cell type.
| Stage | What It Means | Treatment Direction |
|---|---|---|
| Stage I | Small tumor, fully localized | Surgery or radiation alone |
| Stage II | Larger but still contained | Surgery and/or radiation |
| Stage III | Lymph node involvement | Combined chemoradiation |
| Stage IV | Distant spread or bulky disease | Multimodal systemic therapy |
Treatment plan for throat cancer is made based on the tumor type, stage, anatomical location, HPV status, and the patient's baseline health. At HCG, every case goes before a multidisciplinary tumor board before a plan is confirmed.
Surgery: Surgery aims to remove the tumor while preserving as much function as possible. Transoral laser microsurgery works well for confined laryngeal lesions. More extensive tumors may require open resection. Neck dissection is added when lymph node involvement is present or suspected.
Radiotherapy: Radiation therapy using IMRT delivers sculpted doses to the tumor while protecting the salivary glands, spinal cord, and brainstem. Image guidance keeps every session accurate.
Systemic Therapies: Concurrent chemoradiation, combining cisplatin with radiation, is the standard approach for Stage III and IV pharyngeal and laryngeal cancers. The combination improves regional tumor control compared with radiation alone.
Cetuximab, targeting the EGFR pathway, is used when cisplatin is not an option due to kidney function or health status. Pembrolizumab is approved for recurrent or metastatic head and neck squamous cell carcinoma and represents a meaningful option for patients with progressive disease.
Swallowing is often the hardest function to rebuild. Speech-language pathologists work with patients through progressive exercises aimed at restoring safe, comfortable oral intake. Temporary tube feeding during intensive chemoradiation is common and expected, not a setback.
Shoulder physiotherapy follows neck dissection. Voice rehabilitation supports patients treated for laryngeal disease. Psycho-oncology services address the emotional load that comes with any cancer diagnosis and treatment.
Follow-up imaging at three and six months after treatment completion is standard. Annual surveillance continues afterward to detect any recurrence at the earliest opportunity.
Costs typically range from Rs. 200,000 to Rs. 800,000 or more. Early-stage surgical intervention may fall between Rs. 150,000 and Rs. 350,000. Chemoradiation for locally advanced cases generally ranges from Rs. 300,000 to Rs. 700,000. Immunotherapy adds to this total. City location and facility tier affect pricing. Costs vary by hospital and patient profile. Requesting an itemized estimate before beginning treatment is always a reasonable step.
Three weeks of unexplained hoarseness, a neck lump, or swallowing difficulty are enough reasons to get assessed. An evaluation gives you information. Nothing about showing up to a specialist appointment obligates you to any specific treatment plan.
Before that appointment, note when symptoms began and what has changed. Bring any prior ENT reports or imaging. Be honest about tobacco and smokeless-product use. Ask whether HPV testing will be part of the workup. Find out if a tumor board review is standard at your chosen center.
In cancer care, HCG Cancer Hospital focuses on building a coordinated plan around the individual, not the disease category. Head and neck surgical oncologists, radiation oncologists, and medical oncologists collaborate on each case before treatment begins. Throat cancer, when identified accurately and staged correctly, is far more manageable than most patients expect when they first hear the diagnosis. The pathway forward starts with getting a clear clinical picture as early as possible.
Disclaimer: This information is intended to educate patients and caregivers. It does not replace professional medical advice. All treatment decisions should be made in consultation with a qualified doctor.
